Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

ISSN: 2211-5544 (Online)
ISSN: 2211-5552 (Print)

Volume 4, 2 Issues, 2015

Download PDF Flyer

Current Molecular Imaging

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Abass Alavi
Department of Radiology/Nuclear Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA 19104

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

Current Molecular Imaging, 3(1): 15-26.

Author(s): Chun-Kai Fang, Ya-Fang Chang, Hui-Yen Chuang, Hong-Wen Chen and Jeng-Jong Hwang.

Affiliation: Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, No. 155, Sec. 2, Li-Nong St, Bei-tou, Taipei 112, TAIWAN.


Both neuropsychiatric disorders and malignancies of central nervous system (CNS) represent a significant health burden and life-threatening diseases worldwide. Radiotracer-based neuroimaging is an attractive tool that permits the in vivo detection and characterization of metabolic and molecular processes which are fundamental elements for brain function, and improves the theranostics of brain diseases and disorders.

In this review, we outlined the new development of molecular imaging probes for dopamine and serotonin systems in neuropsychiatry and boron neutron capture therapy (BNCT) for brain tumors in neuro-oncology with positron emission tomography (PET) and single-photon emission computed tomography (SPECT).


Boron neutron capture therapy, dopamine, molecular imaging, positron emission tomography, serotonin, singlephoton emission computed tomography.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 3
Issue Number: 1
First Page: 15
Last Page: 26
Page Count: 12
DOI: 10.2174/15748855113089990013

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science